Clinical trial · Observational
Project Affinity: Excess Cancer Blood Testing
Project Affinity: Excess Cancer Blood Testing Technique
NCT04724005CI-TRIAL-00061114completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study investigating cancer blood samples on an iterative measurement systme
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No drug | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Viability of measurement technique
- timeFrame
- 12 months
- description
- Viability of measurement technique
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Undergoing SACT * Routine blood tests Exclusion Criteria: * Not had first cycle of SACT
References
Publications (0)
Data not yet available
No reference posted for this study.